Medicamen Biotech Limited — QIP/Rights/Pref., 26-02-2025: Issue of Securities

Medicamen Biotech Limited has announced a board meeting to approve a preferential issue of up to 13,00,000 equity shares at an issue price of ₹530 each, raising approximately ₹68.90 crore. This allocation includes shares to Veralogix Holdings (PTY) Ltd, Ginnerup Capital APS, Eric Aarestrup Sorensen, and Ritesh Kantilal Oswal. Additionally, up to 6,55,000 fully convertible warrants will be issued at the same price, potentially raising ₹34.71 crore, with holders having the option to convert these into equity shares within 18 months. An extraordinary general meeting is scheduled for March 26, 2025, to seek member approval.